|Real-time Estimate - 08/07 11:30:00 am|
GlaxoSmithKline : REFILE-Sanofi, Glaxo advance talks to supply up to 300 mln COVID-19 vaccine doses to Europe -companies
|07/31/2020 | 03:51pm|
July 31 (Reuters) - Sanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions with the European Commission to supply up to 300 million doses of the drugmakers's experimental COVID-19 vaccine.
The doses would be manufactured in European countries including France, Belgium, Germany and Italy.
Sanofi is leading the clinical development of the vaccine and expects to launch a pivotal trial by the end of this year. (Reporting By Deena Beasley; editing by Grant McCool)